Clinical Trial

Perioperative SDD to Prevent Infectious Complications After Esophagectomy

Study acronym: PERSuaDER
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The primary aim of the PERSuaDER-trial is to evaluate the effect of SDD on infectious complications after esophagectomy, focussed on the prevention of pneumonia
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-09; most recent amendment 2025-02-28.
Status change: Not Yet Recruiting → Recruiting 2025-02-28
Trial Details
NCT Number NCT05865743
Lead Sponsor Radboud University Medical Center
Collaborators: ZonMw: The Netherlands Organisation for Health Research and Development, Universitaire Ziekenhuizen KU Leuven
Conditions Esophageal Cancer
Enrollment 854 participants
Start Date 2024-10-21
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-05